Annual EBIT
-$343.01 M
-$62.34 M-22.21%
31 December 2023
Summary:
SpringWorks Therapeutics annual earnings before interest & taxes is currently -$343.01 million, with the most recent change of -$62.34 million (-22.21%) on 31 December 2023. During the last 3 years, it has fallen by -$296.69 million (-640.46%). SWTX annual EBIT is now -1755.03% below its all-time high of -$18.47 million.SWTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$57.94 M
-$13.02 M-28.98%
30 September 2024
Summary:
SpringWorks Therapeutics quarterly earnings before interest & taxes is currently -$57.94 million, with the most recent change of -$13.02 million (-28.98%) on 30 September 2024. Over the past year, it has increased by +$26.06 million (+31.03%). SWTX quarterly EBIT is now -616.42% below its all-time high of $11.22 million, reached on 31 December 2020.SWTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$295.25 M
+$26.06 M+8.11%
30 September 2024
Summary:
SpringWorks Therapeutics TTM earnings before interest & taxes is currently -$295.25 million, with the most recent change of +$26.06 million (+8.11%) on 30 September 2024. Over the past year, it has increased by +$27.75 million (+8.59%). SWTX TTM EBIT is now -5545.35% below its all-time high of -$5.23 million, reached on 30 September 2018.SWTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SWTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.2% | +31.0% | +8.6% |
| 3 y3 years | -640.5% | -41.7% | -177.3% |
| 5 y5 years | -1755.0% | -278.0% | -511.1% |
SWTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -640.5% | at low | -41.7% | +41.2% | -177.3% | +17.8% |
| 5 y | 5 years | -1755.0% | at low | -616.4% | +41.2% | -537.4% | +17.8% |
| alltime | all time | -1755.0% | at low | -616.4% | +41.2% | -5545.4% | +17.8% |
SpringWorks Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$57.94 M(+29.0%) | -$295.25 M(-8.1%) |
| June 2024 | - | -$44.92 M(-52.2%) | -$321.31 M(-10.6%) |
| Mar 2024 | - | -$93.93 M(-4.6%) | -$359.25 M(+4.7%) |
| Dec 2023 | -$343.01 M(+22.2%) | -$98.46 M(+17.2%) | -$343.01 M(+6.2%) |
| Sept 2023 | - | -$84.00 M(+1.4%) | -$323.00 M(+3.9%) |
| June 2023 | - | -$82.85 M(+6.6%) | -$310.75 M(+4.7%) |
| Mar 2023 | - | -$77.70 M(-1.0%) | -$296.90 M(+5.8%) |
| Dec 2022 | -$280.67 M(+61.8%) | -$78.45 M(+9.4%) | -$280.67 M(+8.8%) |
| Sept 2022 | - | -$71.74 M(+4.0%) | -$258.02 M(+13.6%) |
| June 2022 | - | -$69.01 M(+12.3%) | -$227.17 M(+10.7%) |
| Mar 2022 | - | -$61.47 M(+10.2%) | -$205.18 M(+18.3%) |
| Dec 2021 | -$173.47 M | -$55.80 M(+36.4%) | -$173.47 M(+63.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$40.90 M(-13.0%) | -$106.45 M(+22.1%) |
| June 2021 | - | -$47.02 M(+58.0%) | -$87.15 M(+45.4%) |
| Mar 2021 | - | -$29.76 M(-365.2%) | -$59.95 M(+29.4%) |
| Dec 2020 | -$46.32 M(-21.8%) | $11.22 M(-152.0%) | -$46.32 M(-38.2%) |
| Sept 2020 | - | -$21.59 M(+8.9%) | -$74.91 M(+9.1%) |
| June 2020 | - | -$19.82 M(+22.9%) | -$68.65 M(+7.8%) |
| Mar 2020 | - | -$16.13 M(-7.1%) | -$63.68 M(+7.5%) |
| Dec 2019 | -$59.24 M(+220.4%) | -$17.37 M(+13.3%) | -$59.24 M(+22.6%) |
| Sept 2019 | - | -$15.33 M(+3.2%) | -$48.31 M(+26.4%) |
| June 2019 | - | -$14.85 M(+27.1%) | -$38.22 M(+63.6%) |
| Mar 2019 | - | -$11.69 M(+81.3%) | -$23.36 M(+100.1%) |
| Dec 2018 | -$18.49 M | -$6.45 M(+23.3%) | -$11.68 M(+123.3%) |
| Sept 2018 | - | -$5.23 M | -$5.23 M |
FAQ
- What is SpringWorks Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual EBIT year-on-year change?
- What is SpringWorks Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly EBIT year-on-year change?
- What is SpringWorks Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics TTM EBIT year-on-year change?
What is SpringWorks Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SWTX is -$343.01 M
What is the all time high annual EBIT for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual earnings before interest & taxes is -$18.47 M
What is SpringWorks Therapeutics annual EBIT year-on-year change?
Over the past year, SWTX annual earnings before interest & taxes has changed by -$62.34 M (-22.21%)
What is SpringWorks Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SWTX is -$57.94 M
What is the all time high quarterly EBIT for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly earnings before interest & taxes is $11.22 M
What is SpringWorks Therapeutics quarterly EBIT year-on-year change?
Over the past year, SWTX quarterly earnings before interest & taxes has changed by +$26.06 M (+31.03%)
What is SpringWorks Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SWTX is -$295.25 M
What is the all time high TTM EBIT for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high TTM earnings before interest & taxes is -$5.23 M
What is SpringWorks Therapeutics TTM EBIT year-on-year change?
Over the past year, SWTX TTM earnings before interest & taxes has changed by +$27.75 M (+8.59%)